Contact sensitization to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one and 2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI)

A European multicentre study

T. Menne, P. J. Frosch, N. K. Veien, M. Hannuksela, B. Björkner, J. M. Lachapelle, I. R. White, G. Vejlsgaard, H. J. Schubert, K. E. Andersen, A. Dooms‐Goossens, S. Shaw, J. D. Wilkinson, J. G. Camarasa, J. E. Wahlberg, F. Brandru, F. M. Brandao, H. B. van der Walle, G. Angelini, K. Thestrup‐Edersen & 3 others D. Burrows, G. Ducombs, Antonella Tosti

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The frequency of positive reactions to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI) were studied at 22 European cntact dermatitis clinics over a period of 1 year. A total of 4713 patients participated. All the patients were patch tested with nickel sulphate, formaldehyde, paraben‐mix, and MCI/MI 19.4% of the patients had positive patch tests to nickel, making this the most common allergen, 3% of the patients reacted to 100 ppm MCI/MI, while 2.6% reacted to formaldchyde and 1.1% to parabens. There was great variation in the frequency of MCI/MI sensitivity among the 22 centres. MCI/MI contact allergy was most common among women and in patients with facial dermatitis, while it was rarely seen in patients with dermatitis on the lower legs. There were no fluctuations in the number of positive patch tests to MCI/MI on a monthly basis when the results from all centres were combined. 117 of the 141 MCI/MI sensitized patients included in the study were retested 88% had positive patch tests when retested. 101 of the MCI/MI‐sensitive patients participated in a double ‐blind, placebo‐controlled product use test. This test showed that 31% of the MCI/MI‐sensitive patients had a positive reaction to a MCI/MI‐preserved product. Only a few patients reacted to a control product. It is concluded that the preservative MCI/MI is an important new contact allergen.

Original languageEnglish (US)
Pages (from-to)334-341
Number of pages8
JournalContact Dermatitis
Volume24
Issue number5
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Multicenter Studies
Patch Tests
Dermatitis
Allergens
Parabens
Nickel
Formaldehyde
Leg
Hypersensitivity

Keywords

  • 2‐methyl‐4‐isothiazolin‐3‐one
  • 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one
  • contact allergy
  • cosmetics
  • formaldehyde
  • multicentre study
  • nickel
  • parabens
  • patch testing technique
  • preservatives

ASJC Scopus subject areas

  • Immunology and Allergy
  • Dermatology

Cite this

Contact sensitization to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one and 2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI) : A European multicentre study. / Menne, T.; Frosch, P. J.; Veien, N. K.; Hannuksela, M.; Björkner, B.; Lachapelle, J. M.; White, I. R.; Vejlsgaard, G.; Schubert, H. J.; Andersen, K. E.; Dooms‐Goossens, A.; Shaw, S.; Wilkinson, J. D.; Camarasa, J. G.; Wahlberg, J. E.; Brandru, F.; Brandao, F. M.; van der Walle, H. B.; Angelini, G.; Thestrup‐Edersen, K.; Burrows, D.; Ducombs, G.; Tosti, Antonella.

In: Contact Dermatitis, Vol. 24, No. 5, 1991, p. 334-341.

Research output: Contribution to journalArticle

Menne, T, Frosch, PJ, Veien, NK, Hannuksela, M, Björkner, B, Lachapelle, JM, White, IR, Vejlsgaard, G, Schubert, HJ, Andersen, KE, Dooms‐Goossens, A, Shaw, S, Wilkinson, JD, Camarasa, JG, Wahlberg, JE, Brandru, F, Brandao, FM, van der Walle, HB, Angelini, G, Thestrup‐Edersen, K, Burrows, D, Ducombs, G & Tosti, A 1991, 'Contact sensitization to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one and 2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI): A European multicentre study', Contact Dermatitis, vol. 24, no. 5, pp. 334-341. https://doi.org/10.1111/j.1600-0536.1991.tb01747.x
Menne, T. ; Frosch, P. J. ; Veien, N. K. ; Hannuksela, M. ; Björkner, B. ; Lachapelle, J. M. ; White, I. R. ; Vejlsgaard, G. ; Schubert, H. J. ; Andersen, K. E. ; Dooms‐Goossens, A. ; Shaw, S. ; Wilkinson, J. D. ; Camarasa, J. G. ; Wahlberg, J. E. ; Brandru, F. ; Brandao, F. M. ; van der Walle, H. B. ; Angelini, G. ; Thestrup‐Edersen, K. ; Burrows, D. ; Ducombs, G. ; Tosti, Antonella. / Contact sensitization to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one and 2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI) : A European multicentre study. In: Contact Dermatitis. 1991 ; Vol. 24, No. 5. pp. 334-341.
@article{6415a293514c441f973974e659799b54,
title = "Contact sensitization to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one and 2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI): A European multicentre study",
abstract = "The frequency of positive reactions to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI) were studied at 22 European cntact dermatitis clinics over a period of 1 year. A total of 4713 patients participated. All the patients were patch tested with nickel sulphate, formaldehyde, paraben‐mix, and MCI/MI 19.4{\%} of the patients had positive patch tests to nickel, making this the most common allergen, 3{\%} of the patients reacted to 100 ppm MCI/MI, while 2.6{\%} reacted to formaldchyde and 1.1{\%} to parabens. There was great variation in the frequency of MCI/MI sensitivity among the 22 centres. MCI/MI contact allergy was most common among women and in patients with facial dermatitis, while it was rarely seen in patients with dermatitis on the lower legs. There were no fluctuations in the number of positive patch tests to MCI/MI on a monthly basis when the results from all centres were combined. 117 of the 141 MCI/MI sensitized patients included in the study were retested 88{\%} had positive patch tests when retested. 101 of the MCI/MI‐sensitive patients participated in a double ‐blind, placebo‐controlled product use test. This test showed that 31{\%} of the MCI/MI‐sensitive patients had a positive reaction to a MCI/MI‐preserved product. Only a few patients reacted to a control product. It is concluded that the preservative MCI/MI is an important new contact allergen.",
keywords = "2‐methyl‐4‐isothiazolin‐3‐one, 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one, contact allergy, cosmetics, formaldehyde, multicentre study, nickel, parabens, patch testing technique, preservatives",
author = "T. Menne and Frosch, {P. J.} and Veien, {N. K.} and M. Hannuksela and B. Bj{\"o}rkner and Lachapelle, {J. M.} and White, {I. R.} and G. Vejlsgaard and Schubert, {H. J.} and Andersen, {K. E.} and A. Dooms‐Goossens and S. Shaw and Wilkinson, {J. D.} and Camarasa, {J. G.} and Wahlberg, {J. E.} and F. Brandru and Brandao, {F. M.} and {van der Walle}, {H. B.} and G. Angelini and K. Thestrup‐Edersen and D. Burrows and G. Ducombs and Antonella Tosti",
year = "1991",
doi = "10.1111/j.1600-0536.1991.tb01747.x",
language = "English (US)",
volume = "24",
pages = "334--341",
journal = "Contact Dermatitis",
issn = "0105-1873",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Contact sensitization to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one and 2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI)

T2 - A European multicentre study

AU - Menne, T.

AU - Frosch, P. J.

AU - Veien, N. K.

AU - Hannuksela, M.

AU - Björkner, B.

AU - Lachapelle, J. M.

AU - White, I. R.

AU - Vejlsgaard, G.

AU - Schubert, H. J.

AU - Andersen, K. E.

AU - Dooms‐Goossens, A.

AU - Shaw, S.

AU - Wilkinson, J. D.

AU - Camarasa, J. G.

AU - Wahlberg, J. E.

AU - Brandru, F.

AU - Brandao, F. M.

AU - van der Walle, H. B.

AU - Angelini, G.

AU - Thestrup‐Edersen, K.

AU - Burrows, D.

AU - Ducombs, G.

AU - Tosti, Antonella

PY - 1991

Y1 - 1991

N2 - The frequency of positive reactions to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI) were studied at 22 European cntact dermatitis clinics over a period of 1 year. A total of 4713 patients participated. All the patients were patch tested with nickel sulphate, formaldehyde, paraben‐mix, and MCI/MI 19.4% of the patients had positive patch tests to nickel, making this the most common allergen, 3% of the patients reacted to 100 ppm MCI/MI, while 2.6% reacted to formaldchyde and 1.1% to parabens. There was great variation in the frequency of MCI/MI sensitivity among the 22 centres. MCI/MI contact allergy was most common among women and in patients with facial dermatitis, while it was rarely seen in patients with dermatitis on the lower legs. There were no fluctuations in the number of positive patch tests to MCI/MI on a monthly basis when the results from all centres were combined. 117 of the 141 MCI/MI sensitized patients included in the study were retested 88% had positive patch tests when retested. 101 of the MCI/MI‐sensitive patients participated in a double ‐blind, placebo‐controlled product use test. This test showed that 31% of the MCI/MI‐sensitive patients had a positive reaction to a MCI/MI‐preserved product. Only a few patients reacted to a control product. It is concluded that the preservative MCI/MI is an important new contact allergen.

AB - The frequency of positive reactions to 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one (MCI/MI) were studied at 22 European cntact dermatitis clinics over a period of 1 year. A total of 4713 patients participated. All the patients were patch tested with nickel sulphate, formaldehyde, paraben‐mix, and MCI/MI 19.4% of the patients had positive patch tests to nickel, making this the most common allergen, 3% of the patients reacted to 100 ppm MCI/MI, while 2.6% reacted to formaldchyde and 1.1% to parabens. There was great variation in the frequency of MCI/MI sensitivity among the 22 centres. MCI/MI contact allergy was most common among women and in patients with facial dermatitis, while it was rarely seen in patients with dermatitis on the lower legs. There were no fluctuations in the number of positive patch tests to MCI/MI on a monthly basis when the results from all centres were combined. 117 of the 141 MCI/MI sensitized patients included in the study were retested 88% had positive patch tests when retested. 101 of the MCI/MI‐sensitive patients participated in a double ‐blind, placebo‐controlled product use test. This test showed that 31% of the MCI/MI‐sensitive patients had a positive reaction to a MCI/MI‐preserved product. Only a few patients reacted to a control product. It is concluded that the preservative MCI/MI is an important new contact allergen.

KW - 2‐methyl‐4‐isothiazolin‐3‐one

KW - 5‐chloro‐2‐methyl‐4‐isothiazolin‐3‐one

KW - contact allergy

KW - cosmetics

KW - formaldehyde

KW - multicentre study

KW - nickel

KW - parabens

KW - patch testing technique

KW - preservatives

UR - http://www.scopus.com/inward/record.url?scp=0025726971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025726971&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0536.1991.tb01747.x

DO - 10.1111/j.1600-0536.1991.tb01747.x

M3 - Article

VL - 24

SP - 334

EP - 341

JO - Contact Dermatitis

JF - Contact Dermatitis

SN - 0105-1873

IS - 5

ER -